A rare case of immune thrombocytopenic purpura, secondary to COVID-19.
作者信息
Yang Yang, Zhao Jun, Wu Jian, Teng Yi, Xia Xinyi
机构信息
COVID-19 Research Center, Institute of Laboratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China.
School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.
出版信息
J Med Virol. 2020 Nov;92(11):2358-2360. doi: 10.1002/jmv.26051. Epub 2020 Jul 6.
Abstract
摘要
相似文献
1
A rare case of immune thrombocytopenic purpura, secondary to COVID-19.
J Med Virol. 2020 Nov;92(11):2358-2360. doi: 10.1002/jmv.26051. Epub 2020 Jul 6.
2
Immune thrombocytopenic purpura after COVID-19 infection.
Int J Lab Hematol. 2021 Feb;43(1):e28-e30. doi: 10.1111/ijlh.13346. Epub 2020 Sep 20.
3
Coronavirus disease associated immune thrombocytopenia: Causation or correlation?
J Microbiol Immunol Infect. 2021 Jun;54(3):531-533. doi: 10.1016/j.jmii.2020.08.006. Epub 2020 Aug 18.
4
Isolated immune thrombocytopenic purpura in a young adult Covid-19 patient.
Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10850-10852. doi: 10.26355/eurrev_202010_23447.
5
Immune Thrombocytopenic Purpura in a Child Following a SARS-CoV-2 Infection.
J Pediatr Hematol Oncol. 2021 Nov 1;43(8):e1268-e1269. doi: 10.1097/MPH.0000000000002330.
6
Congenital ADAMTS13 deficiency: a rare mimicker of immune thrombocytopenic purpura.
J Pediatr Hematol Oncol. 2014 Nov;36(8):653-5. doi: 10.1097/MPH.0000000000000180.
7
Immune thrombocytopenia secondary to COVID-19 infection: Report of two cases.
Pediatr Blood Cancer. 2021 Oct;68(10):e29175. doi: 10.1002/pbc.29175. Epub 2021 Jun 1.
8
Successful Treatment of Idiopathic Thrombocytopenic Purpura After Liver Transplant: A Case Report.
Exp Clin Transplant. 2020 Oct;18(5):649-652. doi: 10.6002/ect.2018.0083. Epub 2018 Jul 31.
9
Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.
Br J Haematol. 2021 Dec;195(5):703-705. doi: 10.1111/bjh.17813. Epub 2021 Aug 31.
10
A case of newly diagnosed immune thrombocytopenia in the COVID-19 era.
Intern Emerg Med. 2021 Nov;16(8):2221-2225. doi: 10.1007/s11739-020-02553-3. Epub 2020 Nov 12.
引用本文的文献
1
SARS-CoV-2 infection-induced immune thrombocytopenia: a systematic review of current reports.
Ann Hematol. 2024 Oct;103(10):3921-3939. doi: 10.1007/s00277-024-05765-1. Epub 2024 Apr 23.
2
Cutaneous Manifestations of COVID-19 in the Inpatient Setting.
Dermatol Clin. 2021 Oct;39(4):521-532. doi: 10.1016/j.det.2021.05.011. Epub 2021 May 28.
3
Autoimmune complications of COVID-19.
J Med Virol. 2022 Jan;94(1):54-62. doi: 10.1002/jmv.27292. Epub 2021 Aug 31.
4
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.
J Autoimmun. 2021 Feb;117:102592. doi: 10.1016/j.jaut.2020.102592. Epub 2020 Dec 14.
5
Cutaneous Manifestations in Adult Patients with COVID-19 and Dermatologic Conditions Related to the COVID-19 Pandemic in Health Care Workers.
Curr Allergy Asthma Rep. 2020 Oct 12;20(12):75. doi: 10.1007/s11882-020-00974-w.
6
Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review.
SN Compr Clin Med. 2020;2(11):2048-2058. doi: 10.1007/s42399-020-00521-8. Epub 2020 Sep 19.
本文引用的文献
1
Thrombocytopenia and its association with mortality in patients with COVID-19.
J Thromb Haemost. 2020 Jun;18(6):1469-1472. doi: 10.1111/jth.14848. Epub 2020 May 4.
2
Immune Thrombocytopenic Purpura in a Patient with Covid-19.
N Engl J Med. 2020 Apr 30;382(18):e43. doi: 10.1056/NEJMc2010472. Epub 2020 Apr 15.
3
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
4
Hematological findings in SARS patients and possible mechanisms (review).
Int J Mol Med. 2004 Aug;14(2):311-5.
Zotero 插件